Loading clinical trials...
Loading clinical trials...
Carbapenem Antibiotic Therapy for VIM Carbapenemase-Producing Enterobacteriaceae Infections - A Retrospective Cohort Study
Conditions
Locations
1
France
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France
Start Date
November 21, 2022
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
December 29, 2023
Lead Sponsor
University Hospital, Strasbourg, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions